These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8147202)

  • 1. Fine needle aspiration cytology of breast ductal carcinoma in situ.
    Venegas R; Rutgers JL; Cameron BL; Vargas H; Butler JA
    Acta Cytol; 1994; 38(2):136-43. PubMed ID: 8147202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytologic diagnosis and grading of ductal carcinoma in situ.
    McKee GT; Tildsley G; Hammond S
    Cancer; 1999 Aug; 87(4):203-9. PubMed ID: 10455208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytologic features of ductal carcinoma in situ in fine-needle aspiration of the breast mirror the histopathologic growth pattern heterogeneity and grading.
    Sauer T; Lømo J; Garred O; Naess O
    Cancer; 2005 Feb; 105(1):21-7. PubMed ID: 15593325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nipple aspirate fluid cytology in breast carcinoma.
    Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
    Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine-needle aspiration cytology of lobular carcinoma in situ.
    Ustün M; Berner A; Davidson B; Risberg B
    Diagn Cytopathol; 2002 Jul; 27(1):22-6. PubMed ID: 12112810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytologic features of ductal carcinoma in situ.
    Theocharous C; Greenberg ML
    Diagn Cytopathol; 1996 Dec; 15(5):367-73. PubMed ID: 8989536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic pitfalls of fine needle aspiration cytology for breast disease.
    Kerin MJ; McAnena OJ; Waldron RP; McGuire M; Given HF
    Ir Med J; 1993 May; 86(3):100-1. PubMed ID: 8567233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast fine needle aspiration cytology. Utility as a screening tool for clinically palpable lesions.
    Costa MJ; Tadros T; Hilton G; Birdsong G
    Acta Cytol; 1993; 37(4):461-71. PubMed ID: 8328240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-needle aspiration cytology of breast carcinoma with endocrine differentiation.
    Tse GM; Ma TK
    Cancer; 2000 Oct; 90(5):286-91. PubMed ID: 11038425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of large sections on the study of in situ and invasive duct carcinoma of the breast.
    Foschini MP; Flamminio F; Miglio R; Calò DG; Cucchi MC; Masetti R; Eusebi V
    Hum Pathol; 2007 Dec; 38(12):1736-43. PubMed ID: 17714759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.
    Giardina C; Serio G; Lepore G; Lettini T; Dalena AM; Pennella A; D'Eredità G; Valente T; Ricco R
    J Exp Clin Cancer Res; 2003 Jun; 22(2):279-88. PubMed ID: 12866579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-grade cribriform ductal carcinoma in situ of the breast. Fine needle aspiration cytology in three cases.
    Lilleng R; Hagmar BM; Farrants G
    Acta Cytol; 1992; 36(1):48-54. PubMed ID: 1312285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of ductal carcinoma in-situ of breast and its correlation with the grade of associated invasive component.
    Konar K; Chatterjee U; Dutta SK
    Indian J Pathol Microbiol; 2001 Jul; 44(3):297-300. PubMed ID: 12024916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies.
    Renshaw AA; Cartagena N; Schenkman RH; Derhagopian RP; Gould EW
    Am J Clin Pathol; 2001 Jul; 116(1):92-6. PubMed ID: 11447758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up.
    Simsir A; Waisman J; Thorner K; Cangiarella J
    Cancer; 2003 Jun; 99(3):156-65. PubMed ID: 12811856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.